Lanean...

Microtubule inhibitor-based antibody–drug conjugates for cancer therapy

The specificity of monoclonal antibodies represents a potential therapeutic advantage, but their use as single agents in oncology has proven limited to date. The development of antibody-drug conjugates (ADCs) takes advantage of the specificity of the monoclonal antibody and potent cytotoxic effect o...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Onco Targets Ther
Egile Nagusiak: Klute, Kelsey, Nackos, Eleni, Tasaki, Shinsuke, Nguyen, Daniel P, Bander, Neil H, Tagawa, Scott T
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Dove Medical Press 2014
Gaiak:
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4259504/
https://ncbi.nlm.nih.gov/pubmed/25506226
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S46887
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!